Bristol-Myers Squibb News
Most Popular Bristol-Myers Squibb Story
It's final: Tasigna in, Sprycel out in NICE guidelines
The National Institute for Health and Clinical Excellence has struck again. Despite two appeals of its draft recommendations, the agency let in only one new drug for chronic myeloid leukemia. Read more...
Latest Headlines
- February 8, 2012
- January 26, 2012
- January 25, 2012
- January 13, 2012
- January 11, 2012
- January 11, 2012
- January 10, 2012
- January 9, 2012
- January 5, 2012
- January 3, 2012
- December 19, 2011
- December 6, 2011
- November 30, 2011
- November 29, 2011
- November 28, 2011
- November 18, 2011
- November 17, 2011
- November 15, 2011
- November 14, 2011
- November 14, 2011
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
